Amedisys, Inc. (AMED) Tops Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Net income attributable to noncontrolling interests: -66K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Net income attributable to noncontrolling interests: -66K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Amedisys, Inc. (NASDAQ: AMED) reported Q3 EPS of $0.33, $0.06 better than the analyst estimate of $0.27. Revenue for the quarter came in at $375.63 million versus the consensus estimate of $379.97 million.
For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.
For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citadel sees year-end stock rally as Wall Street’s biggest buyers return
- Berkshire Hathaway hits 52-week high on election rally
- Netflix gains after Ackman endorsement and AI feature launch
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
